Mackenzie Financial’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Mackenzie Financial’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-109,754	Closed	-$1.64M	–	940
2016 Q2	$1.64M	Buy	109,754 +29,600	+37%	+$380K	0.01%	485
2016 Q1	$975K	Sell	80,154 -120,400	-60%	-$1.69M	0.01%	517
2015 Q4	$3.19M	Buy	200,554 +9,100	+5%	+$143K	0.02%	350
2015 Q3	$2.94M	Sell	191,454 -1,500	-0.8%	-$32.4K	0.02%	350
2015 Q2	$4.69M	Sell	192,954 -40,600	-17%	-$973K	0.03%	313
2015 Q1	$5.43M	Buy	233,554 +6,954	+3%	+$184K	0.03%	312
2014 Q4	$5.69M	Buy	226,600 +1,800	+0.8%	+$52.8K	0.03%	308
2014 Q3	$6.99M	Sell	224,800 -4,600	-2%	-$125K	0.04%	287
2014 Q2	$5.93M	Sell	229,400 -82,800	-27%	-$1.84M	0.03%	313
2014 Q1	$7.3M	Buy	312,200 +31,900	+11%	+$698K	0.04%	284
2013 Q4	$7.11M	Buy	+280,300	New	+$6.33M	0.04%	270

Mackenzie Financial's SGNT Position: Q3 2016 in Review

Mackenzie Financial sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 109,754 shares — an estimated $1.64M sold.

Mackenzie Financial first reported a position in SGNT in Q4 2013 and held it in 11 quarters. The position peaked at $7.3M in Q1 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Mackenzie Financial reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Mackenzie Financial sold 109,754 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $1.64M.
Mackenzie Financial first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 11 quarters.
Mackenzie Financial's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $7.3M in Q1 2014.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Mackenzie Financial's 13F filing for Q3 2016, filed 15 Nov 2016.